[14C] BIIB122 ([14C] DNL151)

DRUG2 trials

Sponsors

Biogen

Conditions

Healthy Volunteers

Phase 1

A Study to Determine the Absolute Bioavailability of BIIB122/DNL151 in Healthy Subjects

CompletedNCT05005338

BiogenHealthy Volunteers

Start: 2021-07-28End: 2021-09-23Updated: 2021-11-17

A Study of Mass Balance, Pharmacokinetics, Metabolite Profile, and Metabolite Identification of BIIB122/DNL151 in Healthy Male Subjects

CompletedNCT05119790

BiogenHealthy Volunteers

Start: 2021-08-27End: 2021-11-05Updated: 2021-12-07